Ezra Cohen to Histocompatibility Antigens Class II
This is a "connection" page, showing publications Ezra Cohen has written about Histocompatibility Antigens Class II.
Connection Strength
0.041
-
HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer. Cancer Res. 2020 02 15; 80(4):732-746.
Score: 0.041
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.